Groovy.Bio

The annual accounts of Groovy.Bio for financial year 2025 show a net loss of 91% of the equity at the start of that year. The 2025 annual accounts show equity of €544,484 and a net result of -€297,520. Equity is growing by about 74% per year across the filed financial years. Its solvency ranks better than 80% of 62 sector peers (NACE 21, financial year 2025). The company has been active since 2021 and the Belgian Official Gazette contains no insolvency or warning signals. The computed 12-month bankruptcy probability is 1.0% (low).